GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Spexis AG (STU:29Y) » Definitions » PB Ratio

Spexis AG (STU:29Y) PB Ratio : 30.65 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Spexis AG PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-26), Spexis AG's share price is €10.36. Spexis AG's Book Value per Share for the quarter that ended in Jun. 2023 was €0.34. Hence, Spexis AG's PB Ratio of today is 30.65.

The historical rank and industry rank for Spexis AG's PB Ratio or its related term are showing as below:

STU:29Y' s PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.52   Max: 21.15
Current: 0.23

During the past 10 years, Spexis AG's highest PB Ratio was 21.15. The lowest was 0.01. And the median was 0.52.

STU:29Y's PB Ratio is ranked better than
98.17% of 1312 companies
in the Biotechnology industry
Industry Median: 2.5 vs STU:29Y: 0.23

During the past 12 months, Spexis AG's average Book Value Per Share Growth Rate was -40.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -56.60% per year.

During the past 10 years, the highest 3-Year average Book Value Per Share Growth Rate of Spexis AG was 47.50% per year. The lowest was -61.30% per year. And the median was -33.95% per year.

Back to Basics: PB Ratio


Spexis AG PB Ratio Historical Data

The historical data trend for Spexis AG's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spexis AG PB Ratio Chart

Spexis AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.61 2.27 - 17.01 25.15

Spexis AG Semi-Annual Data
Dec13 Dec14 Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 17.01 19.26 25.15 30.65

Competitive Comparison of Spexis AG's PB Ratio

For the Biotechnology subindustry, Spexis AG's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Spexis AG's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Spexis AG's PB Ratio distribution charts can be found below:

* The bar in red indicates where Spexis AG's PB Ratio falls into.



Spexis AG PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Spexis AG's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=10.36/0.338
=30.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Spexis AG  (STU:29Y) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Spexis AG PB Ratio Related Terms

Thank you for viewing the detailed overview of Spexis AG's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Spexis AG (STU:29Y) Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 125, Allschwil, CHE, CH-4123
Spexis AG is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of antibiotics and other specialty pharma products for severe or life-threatening diseases. The company's lead product, murepavadin, is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by World Health Organization. It has one operating segment focusing on the research and development and prospective commercialization of respiratory therapeutics addressing high unmet medical needs.

Spexis AG (STU:29Y) Headlines

No Headlines